Physician profile
Senthil Sukumar
NPI 1356737563
$31,269.04
in general payments reported to CMS, 2019-2025
8 companies · $15K in 2025
The $15K reported for 2025 was more than what 81% of Hematology (Internal Medicine) providers received nationally (typical 2025 total: $1,177).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $128 · 2022: $8,634 · 2023: $3,449 · 2024: $4,280 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,900 · Food and Beverage: $1,369 · Travel and Lodging: $682 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,470.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,900.00 |
| Food and Beverage | $1,368.90 |
| Travel and Lodging | $681.76 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $19,455.59 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $8,203.88 | 2024-2025 | |
| Alexion Pharmaceuticals, INC. | $3,079.34 | 2023-2025 | Ultomiris, Soliris |
| Novo Nordisk INC | $245.10 | 2023 | Rebinyn |
| Sanofi-Aventis U.S. LLC | $128.46 | 2021 | |
| Agios Pharmaceuticals, INC. | $101.34 | 2023 | Pyrukynd |
| Boston Scientific Corporation | $55.33 | 2023 | Lithovue |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Senthil Sukumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.